There is a close association between PTGS2 and depression, involving multiple aspects, including neuroinflammation, neurotransmitter metabolism, neuroplasticity, and hypothalamic–pituitary–adrenal (HPA) axis function (He et al. 2022). This evidence concerns the gene PTGS2 and depressive symptom measurement.